In 2024, 31.7 percent of adults and 29.5 percent of children had diagnosed seasonal allergy, eczema, or food allergy

Findings show significant risk for asthma, allergic rhinitis, or atopic dermatitis

Severity of Alopecia Tool score ≤20 at week 24 achieved by 34.9, 40.6, and 9.0 percent of patients receiving 4 mg, 8 mg ivarmacitinib,...

Median progression-free survival 7.5 months among 22 patients who underwent surgery for vaginal or vulvar melanoma

Biologics do not affect cancer progression, while predictors of progression include advanced cancer stage, higher comorbidity burden

Women had improved survival without immunotherapy, but similar survival with immunotherapy

Review of randomized controlled trials shows interventions improve psoriasis severity and quality of life

Data from four randomized clinical trials confirm benefits by day 2 in atopic dermatitis, prurigo nodularis

Negligible additional risk for recurrence seen after 5FU or surgical excision; negligible risk for cutaneous squamous cell carcinoma reported from treated BD

Furthermore, iron deficiency is associated with higher clinical burden

Significant reduction seen in the mean Worst Itch Numeric Rating Scale scores for high-, mid-, low-dose vixarelimab versus placebo

The U.S. Food and Drug Administration is reviewing bemotrizinol, a sunscreen ingredient used widely overseas

Tanning bed users more likely to have melanoma on body sites with low cumulative levels of sun damage, to have multiple melanomas

Adjusted hazard ratio for progression-free and overall survival significantly lower for NIVO3+IPI1 versus NIVO1+IPI3

Mendelian randomization analyses support effect of BMI and IBD, with no signs of pleiotropy

High rates of complete response seen for ischemia, ulcers, gangrene; adverse events occurred infrequently

Of four patients receiving retreatment with cemiplimab, three remained progression-free at data cutoff

Significant improvements seen in coprimary end points of EASI-75 response and vIGA-AD score of 0 or 1 versus placebo

With ultrasound findings, the exact place where the occlusion occurs can be targeted

Model achieved area under the curve values of 0.7577, 0.7595, and 0.7557 for one-, three-, and five-year survival predictions

Ambient light and polarized dermatoscopes both enable dermoscopy performance and receipt of teledermatology recommendations

Approval is for adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation

Age-standardized incidence rate projected to continue increasing through 2050 in males and females based on data through 2021